Book a Consult
94% Patient Satisfaction: The ZEISS CT LUCIA® 621P Study Spotlight
As the world marks World Sight Day 2025, we are reminded of the vital importance of protecting and restoring vision, a goal that unites clinicians, researchers and industry leaders across the globe. This year’s call to love your eyes emphasizes not only awareness but action, ensuring that everyone has access to the care and technology needed to see life clearly. Within this shared commitment to better eye health, the ZEISS CT LUCIA® 621P represents how innovation can make a lasting difference.
Setting a New Standard in Monofocal IOLs
Designed with precision and reliability in mind, the ZEISS CT LUCIA® 621P enables surgeons to deliver outstanding visual quality, secure positioning and lasting patient satisfaction.
On this World Sight Day, we acknowledge the six month clinical study that showcases how continuous innovation in intraocular lens design can truly enhance patients’ quality of vision and life. The findings reaffirm what many surgeons already recognize in their daily practice, the CT LUCIA® 621P delivers clarity that extends far beyond the operating room.
Clinical Evidence in Focus
Advances in intraocular lens design are most meaningful when supported by robust clinical data. To further validate the performance of the ZEISS CT LUCIA® 621P, a large scale retrospective study was conducted to assess visual outcomes, stability and patient satisfaction following bilateral implantation.
The results offer valuable insights into how this lens performs in real world conditions, confirming its role as a dependable option for surgeons seeking consistency and patients striving for clear, comfortable vision.
Study Overview
The research, published in Clinical Ophthalmology (2025), evaluated outcomes following bilateral implantation of the CT LUCIA 621P
Methodology
• Retrospective study, postoperative patient satisfaction questionnaire, bilateral implantation, preoperative corneal astigmatism ≤ 1.50 D
• Data extracted from the electronic medical record of Optical Express, UK
• Postoperative examination was conducted up to 6-months after surgery
Results
The clinical trial demonstrates “high patient satisfaction and visual performance” with ZEISS CT LUCIA 621P postoperatively after 6 months
Visual Acuity Outcomes
- Visual clarity was a consistent highlight of the study.
- 85.6% of patients achieved corrected distance visual acuity (CDVA) of 20/20 or better within six months.
- This level of performance underscores the optical precision of the lens and demonstrates its ability to meet the high standards surgeons expect from ZEISS.
Patient Satisfaction
- The CT LUCIA 621P also delivered strong satisfaction rates:
- 94.8% of patients reported being satisfied to very satisfied with their visual outcomes.
- 97.9% stated they would undergo the surgery again.
- 99% said they would recommend the procedure to friends or family.
Visual Phenomena
Minimizing visual disturbances is essential for everyday comfort. The study showed a very low incidence of reported issues:
- 72.2% experienced no difficulty with glare
- 89.7% reported no difficulty with halos
- 85.6% reported no difficulty with starbursts
- 89.7% reported no difficulty with ghosting/double vision
Below figure illustrates how most patients reported no difficulty with these visual phenomena throughout the follow-up period.
What This Means for Surgeons
These findings confirm that the CT LUCIA 621P offers:
- Reliable implantation through its ergonomic injector system
- Secure centering and stability thanks to its refined haptic design
- Strong real-world outcomes validated by clinical evidence
- High patient trust reflected in satisfaction and willingness to recommend surgery
The ZEISS CT LUCIA® 621P is more than a well-designed lens—it’s a solution validated by evidence. The six-month study demonstrates excellent visual acuity, high patient satisfaction, and minimal visual disturbances, making it a trusted choice for surgeons aiming for predictable, patient-centered outcomes.
References
Schallhorn SC, Teenan D, Venter JA, Schallhorn JM, Hannan SJ. Preliminary Evaluation of Clinical and Non-Clinical Outcome Metrics in Patient Satisfaction After Implantation of a Non-Constant Aberration Correcting Monofocal IOL. Clinical Ophthalmology. 2025;19:795–806. DOI: https://doi.org/10.2147/OPTH.S505584
Get in Touch to Learn More
For detailed information or to view the available sets, please reach out to our product specialist:
Ourvashi Sumoondur
Field Engineer
UrvashiS@medtech.mu
+230 5 938 9225
🔴 Book a Consultation
📘 Download ZEISS IOLs Portfolio Brochure